EP3628319
MEÐFERÐ VIÐ LIFRARHEILAKVILLA MEÐ RIFAXIMÍNI
:
EP einkaleyfi í gildi á Íslandi:
2.10.2009:
14.2.2024:
19207534.9
:
6.3.2024:
15.4.2024
:
1.10.2029:
1.10.2025:
31.10.2025
:
TREATMENT OF HEPATIC ENCEPHALOPATHY USING RIFAXIMIN
2.10.2009
14.2.2024
6.3.2024
15.4.2024
1.10.2025
:
Salix Pharmaceuticals, Ltd.:
400 Somerset Corporate Blvd., Bridgewater, NJ 08807, US
:
FORBES, William:
Raleigh, NC 27164, US
:
Novagraaf Brevets:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
:
102349 P:
2.10.2008:
US
:
A61K 31/437, A61K 45/06, A61K 31/08, A61K 31/352, A61K 31/4164, A61K 31/426, A61K 31/4439, A61K 31/606, A61K 31/7016, A61K 31/785, A61K 38/14, A61K 38/31, A61P 1/16, A61K 31/395
: 16
: 17.9.2024
: 1.10.2025
: Árnason Faktor ehf.